US Patent Issued to INSTITUT PASTEUR, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) on Aug. 4 for "Antibody blocking human FcGammaRIIIA and FcGammaRIIIB" (French Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,331, issued on Aug. 4, was assigned to INSTITUT PASTEUR (Paris), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (Paris) and INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris).

"Antibody blocking human FcGammaRIIIA and FcGammaRIIIB" was invented by Pierre Bruhns (Paris), Odile Madeleine Richard-Le Goff (Paris), Patrick Evan England (Le Perreux-sur-Marne, France), Sylviane Hoos (Sceaux, France) and Friederike Jonsson (Antony, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to novel antibodies, in particular murine monoclonal antibodies, chimeric and humanized, that are able to block speci...